AstraZeneca PLC is 168.7x more valuable than uniQure N.V. by market capitalization ($286.27 B vs $1.70 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | QURE | AZN |
|---|---|---|
| Market cap | $1.70 B | $286.27 B |
| US-listed rank | #2229 | #45 |
| Revenue (latest FY) | $13.11M | - |
| Net income (latest FY) | -$199.00M | - |
| Net margin | -1518.3% | - |
| SEC filings | 888 | 1,004 |
AstraZeneca PLC is 168.7x more valuable than uniQure N.V. by market capitalization ($286.27 B vs $1.70 B).
Full pages: uniQure N.V. and AstraZeneca PLC, or browse the full rankings.